A 2-point improvement in pain based on a numeric rating scale may indicate that patients are responding to treatment for pyoderma gangrenosum. To help determine whether a patient with pyoderma ...

Pain as a patient-reported outcome measure during the treatment of pyoderma gangrenosum may indicate whether a patient is responding to treatment, according to a research letter published in JAMA ...

InflaRx has initiated a phase 3 study of vilobelimab in patients with ulcerative pyoderma gangrenosum, the company announced in a press release. The multinational, randomized, double-blind ...

Sometimes, pyoderma gangrenosum improves with good control of your underlying condition. But you can also get it when you’re in remission, and even after you’ve had your colon removed.

The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ulcerative pyoderma gangrenosum (PG), a rare skin disorder characterized by chronic ...

In pyoderma gangrenosum, a blister or nodule on the skin rapidly expands and forms an ulcer, usually on the leg or trunk. The lesion often is quite tender. A biopsy almost always is performed to ...